AFP and hepatocellular carcinoma: Its high HCC-specific transcriptional activity is ensured by hepatocyte nuclear factors 1(HNF1), C/EBP, HNF3 and HNF4 binding to several cis-acting liver-enriched transcription factors (LETFs) binding sites in AFP enhancer [21,30].